Highlights Ulisse Biomed S.p.A.

Equities

Real-time Borsa Italiana Other stock markets 08:13:58 2024-05-14 am EDT			5-day change	1st Jan Change
1.205 ^EUR	+1.26%		+3.43%	-27.19%

May. 09	Ulisse Biomed, Sbaizero resigns as independent director	AN
May. 03	Ulysses Biomed reduces loss in 2023; NFP is positive	AN

Ulysses Biomed reduces loss in 2023; NFP is positive	May. 03	AN
Mib in the red; Stellantis gives up double digits	Apr. 30	AN
Ulisse Biomed, subsidiary sign distribution agreement with Mediline	Mar. 18	AN
Ulisse Biomed, subsidiary sign partnership agreement with Generon	Mar. 04	AN
Ulysses Biomed subsidiary concludes project worth more than EUR1 million	Feb. 20	AN
Banks weigh on Mib in the red	Feb. 13	AN
Hyris Fulfils Its Integration into Ulisse Biomed to Give Birth to A New International Group	Jan. 15	CI
Futures bearish; new US data expected.	Jan. 03	AN
Good banks and oil, Mib opens the year higher	Jan. 02	AN
Ulysses Biomed, board of directors and board of auditors resign	Dec. 29	AN
Ulysses Biomed, subsidiary sign agreement for agricultural test development	Dec. 28	AN
Ulisse Biomed approves reverse take-over and aucap; Lo Priore new chair	Dec. 21	AN
Ulysses Biomed, binding agreement to purchase 100 percent of Hyris	Dec. 05	AN
Hyris Ltd. agreed to acquire Ulisse Biomed S.p.A. (BIT : UBM) on December 5, 2023.	Dec. 04	CI
Microbix Biosystems Inc. Announces Collaboration with Ulisse Biomed S.P.A	Nov. 10	CI
Ulisse Biomed S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-29	CI
Ulisse Biomed worsens half-year loss; revenues drop	23-09-29	AN
Ulysses Biomed doubles loss in 2022; improves NFP	23-03-28	AN
Ulisse Biomed S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-27	CI
Ulysses Biomed announces new worldwide distribution agreement	23-02-13	AN

No results for this search